Allianz Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-117,856
| Closed | -$21.7M | – | 2731 |
|
|
2021
Q2 | $21.7M | Buy |
117,856
+15,074
| +15% | +$2.59M | 0.02% | 610 |
|
|
2021
Q1 | $15.7M | Sell |
102,782
-17,707
| -15% | -$2.74M | 0.02% | 690 |
|
|
2020
Q4 | $18.8M | Sell |
120,489
-110,513
| -48% | -$14.2M | 0.02% | 643 |
|
|
2020
Q3 | $26.4M | Sell |
231,002
-36,709
| -14% | -$3.96M | 0.03% | 477 |
|
|
2020
Q2 | $30M | Buy |
267,711
+67,921
| +34% | +$7.21M | 0.04% | 482 |
|
|
2020
Q1 | $17.9M | Sell |
199,790
-27,600
| -12% | -$2.71M | 0.03% | 606 |
|
|
2019
Q4 | $24.6M | Buy |
227,390
+21,340
| +10% | +$2.28M | 0.03% | 698 |
|
|
2019
Q3 | $20.2M | Buy |
206,050
+3,288
| +2% | +$371K | 0.02% | 764 |
|
|
2019
Q2 | $26.6M | Sell |
202,762
-14,693
| -7% | -$1.89M | 0.03% | 686 |
|
|
2019
Q1 | $29.4M | Buy |
217,455
+60,543
| +39% | +$7.53M | 0.03% | 601 |
|
|
2018
Q4 | $15.3M | Buy |
156,912
+3,269
| +2% | +$386K | 0.02% | 860 |
|
|
2018
Q3 | $21.4M | Sell |
153,643
-18,456
| -11% | -$2.32M | 0.02% | 861 |
|
|
2018
Q2 | $21.4M | Buy |
172,099
+132,747
| +337% | +$15.5M | 0.02% | 845 |
|
|
2018
Q1 | $4.39M | Sell |
39,352
-111,059
| -74% | -$13.3M | ﹤0.01% | 1588 |
|
|
2017
Q4 | $18M | Sell |
150,411
-102,007
| -40% | -$12.4M | 0.02% | 1035 |
|
|
2017
Q3 | $35.4M | Sell |
252,418
-75,029
| -23% | -$10.2M | 0.04% | 667 |
|
|
2017
Q2 | $39.9M | Buy |
327,447
+121,593
| +59% | +$14.2M | 0.05% | 600 |
|
|
2017
Q1 | $25M | Sell |
205,854
-41,465
| -17% | -$5.35M | 0.03% | 881 |
|
|
2016
Q4 | $30.3M | Sell |
247,319
-151,139
| -38% | -$18.5M | 0.04% | 803 |
|
|
2016
Q3 | $48.4M | Sell |
398,458
-503,669
| -56% | -$64.8M | 0.06% | 482 |
|
|
2016
Q2 | $105M | Sell |
902,127
-88,137
| -9% | -$12.5M | 0.14% | 196 |
|
|
2016
Q1 | $138M | Buy |
990,264
+158,620
| +19% | +$23.3M | 0.18% | 133 |
|
|
2015
Q4 | $159M | Buy |
831,644
+39,601
| +5% | +$6.92M | 0.2% | 112 |
|
|
2015
Q3 | $124M | Sell |
792,043
-64,681
| -8% | -$11.8M | 0.16% | 135 |
|
|
2015
Q2 | $155M | Sell |
856,724
-101,760
| -11% | -$17.6M | 0.18% | 117 |
|
|
2015
Q1 | $166M | Buy |
958,484
+217,557
| +29% | +$39.4M | 0.2% | 106 |
|
|
2014
Q4 | $137M | Buy |
740,927
+492,503
| +198% | +$91.3M | 0.17% | 131 |
|
|
2014
Q3 | $41.2M | Sell |
248,424
-18,554
| -7% | -$3.05M | 0.05% | 402 |
|
|
2014
Q2 | $41.7M | Sell |
266,978
-91,166
| -25% | -$14.4M | 0.05% | 380 |
|
|
2014
Q1 | $54.5M | Sell |
358,144
-66,080
| -16% | -$10.5M | 0.07% | 330 |
|
|
2013
Q4 | $56.4M | Sell |
424,224
-24,085
| -5% | -$2.89M | 0.07% | 322 |
|
|
2013
Q3 | $52.1M | Buy |
448,309
+45,108
| +11% | +$4.95M | 0.07% | 335 |
|
|
2013
Q2 | $37.2M | Buy |
+403,201
| New | +$38.9M | 0.05% | 374 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM